Ignite Creation Date:
2024-05-06 @ 12:17 PM
Last Modification Date:
2024-10-26 @ 12:56 PM
Study NCT ID:
NCT03721172
Status:
COMPLETED
Last Update Posted:
2024-05-29
First Post:
2018-10-09
Brief Title:
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo an Analysis of Clinical Safety and Efficacy
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
CC-10004-PSOR-022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None